Prospective evaluation of the efficacy of dermal botulinium toxin for primary axillary hyperhidrosis

Irish Journal of Medical Science

Volumn 175, Issue 1, 2006, Pages 57-58

  Hanlon, L ^a   Cahill, R ^a   Barry, Mary C ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ARTICLE; AXILLA; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; GRAVIMETRY; HUMAN; HYPERHIDROSIS; NON INVASIVE PROCEDURE; PROSPECTIVE STUDY; PSYCHOLOGICAL WELL BEING; PSYCHOMETRY; QUESTIONNAIRE; SWEATING;

EID: 33645746401     PISSN: 00211265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03169003     Document Type: Article

References (5)

1. Heckman M, Ceballos-Baumann AO, Plewig G. Botulinim toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med 2001;7:488-93.
2. Naumann M, Lowe NJ. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial. Br Med J 2001;323:596-9.
3. Schnider P, Binder M, Kittler H et al. A randomised, double-blind, placebo-controlled trial of botulinum A toxin for severe axillary hyperhidrosis. Br J Dermatol 1999;140:677-680.
4. Naumann M, Lowe NJ, on behalf of the Hyperhidrosis Clinical Study Group. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial. Br Med J 2001:323:1
5. Ojimba TA, Cameron AEP. Drawbacks of endoscopic thoracic sympathectomy. Br J Surg 2004;91:264-269.